2020
DOI: 10.1016/j.csbj.2020.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Deep graph embedding for prioritizing synergistic anticancer drug combinations

Abstract: Drug combinations are frequently used for the treatment of cancer patients in order to increase efficacy, decrease adverse side effects, or overcome drug resistance. Given the enormous number of drug combinations, it is cost-and time-consuming to screen all possible drug pairs experimentally. Currently, it has not been fully explored to integrate multiple networks to predict synergistic drug combinations using recently developed deep learning technologies. In this study, we proposed a Graph Convolutional Netwo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
54
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 79 publications
(56 citation statements)
references
References 58 publications
0
54
0
Order By: Relevance
“…GEDFN approach recently has been used to solve various biomedical problems such as identifying microbial biomarkers from operational taxonomic unit abundance [22], predicting clinical outcomes [23] and prioritizing synergistic anticancer drug combinations. [24].…”
Section: Related Work On Graph Embeddingmentioning
confidence: 99%
“…GEDFN approach recently has been used to solve various biomedical problems such as identifying microbial biomarkers from operational taxonomic unit abundance [22], predicting clinical outcomes [23] and prioritizing synergistic anticancer drug combinations. [24].…”
Section: Related Work On Graph Embeddingmentioning
confidence: 99%
“…There are also DDI studies specific to a group of drugs or to drugs used to treat a specific disease, rather than focusing on the entire drug network. For example, various studies have been conducted on cancer prevention drugs 28 , 29 ; others tackled high blood pressure patients; and some medications used in the treatment 30 , 31 . In these studies, only the risks and interactions for the examined group are calculated.…”
Section: Related Workmentioning
confidence: 99%
“…There are also DDI studies speci c to a group of drugs or to drugs used to treat a speci c disease, rather than focusing on the entire drug network. For example; various studies have been conducted on cancer prevention drugs, e.g., (Jiang et al, 2020;Preuer et al, 2018) or on high blood pressure patients or medications used in the treatment, e.g., (Bacic-Vrca et al, 2010;Martha et al, 2015). In these studies, only the risks and interactions for the examined group are calculated.…”
Section: B Computer Based Ddi Studiesmentioning
confidence: 99%